Correlation Between Unicycive Therapeutics and Dynavax Technologies
Can any of the company-specific risk be diversified away by investing in both Unicycive Therapeutics and Dynavax Technologies at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Unicycive Therapeutics and Dynavax Technologies into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Unicycive Therapeutics and Dynavax Technologies, you can compare the effects of market volatilities on Unicycive Therapeutics and Dynavax Technologies and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Unicycive Therapeutics with a short position of Dynavax Technologies. Check out your portfolio center. Please also check ongoing floating volatility patterns of Unicycive Therapeutics and Dynavax Technologies.
Diversification Opportunities for Unicycive Therapeutics and Dynavax Technologies
0.78 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Unicycive and Dynavax is 0.78. Overlapping area represents the amount of risk that can be diversified away by holding Unicycive Therapeutics and Dynavax Technologies in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Dynavax Technologies and Unicycive Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Unicycive Therapeutics are associated (or correlated) with Dynavax Technologies. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Dynavax Technologies has no effect on the direction of Unicycive Therapeutics i.e., Unicycive Therapeutics and Dynavax Technologies go up and down completely randomly.
Pair Corralation between Unicycive Therapeutics and Dynavax Technologies
Given the investment horizon of 90 days Unicycive Therapeutics is expected to generate 4.75 times more return on investment than Dynavax Technologies. However, Unicycive Therapeutics is 4.75 times more volatile than Dynavax Technologies. It trades about 0.04 of its potential returns per unit of risk. Dynavax Technologies is currently generating about 0.02 per unit of risk. If you would invest 73.00 in Unicycive Therapeutics on September 12, 2024 and sell it today you would earn a total of 5.10 from holding Unicycive Therapeutics or generate 6.99% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Unicycive Therapeutics vs. Dynavax Technologies
Performance |
| Timeline |
| Unicycive Therapeutics |
| Dynavax Technologies |
Unicycive Therapeutics and Dynavax Technologies Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Unicycive Therapeutics and Dynavax Technologies
The main advantage of trading using opposite Unicycive Therapeutics and Dynavax Technologies positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Unicycive Therapeutics position performs unexpectedly, Dynavax Technologies can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Dynavax Technologies will offset losses from the drop in Dynavax Technologies' long position.| Unicycive Therapeutics vs. Transcode Therapeutics | Unicycive Therapeutics vs. Cardio Diagnostics Holdings |
| Dynavax Technologies vs. Evoke Pharma | Dynavax Technologies vs. Lantheus Holdings | Dynavax Technologies vs. ANI Pharmaceuticals | Dynavax Technologies vs. Ironwood Pharmaceuticals |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Theme Ratings module to determine theme ratings based on digital equity recommendations. Macroaxis theme ratings are based on combination of fundamental analysis and risk-adjusted market performance.
Other Complementary Tools
| Cryptocurrency Center Build and monitor diversified portfolio of extremely risky digital assets and cryptocurrency | |
| Fundamental Analysis View fundamental data based on most recent published financial statements | |
| Portfolio Holdings Check your current holdings and cash postion to detemine if your portfolio needs rebalancing | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets |